Dr. Juan Marcos Gonzalez, Phd, is an Assistant Professor in the School of Medicine at Duke University. With more than nine years of experience leading industry-sponsored health-preference studies, Dr. Gonzalez has had pivotal roles in establishing stated-preference methods as an essential tool in patient-centered health care. He has worked with discrete-choice experiments to investigate patients’ and physicians’ treatment preferences in several therapeutic areas, including cancer, psoriasis, and vaccine-preventable diseases. Dr. Gonzalez also led the first FDA-sponsored preference study evaluating benefit-risk tradeoffs for weight-loss devices. This work was highlighted in FDA’s recent precedent-setting guidance for submitting patient-preference evidence to inform regulatory benefit-risk evaluations of medical devices.
As a member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Conjoint Analysis Task Force, Dr. Gonzalez made significant contributions to defining good-practice recommendations for statistical analysis, interpretation, and reporting of health preference data. He was also among a small group of health preference researchers commissioned to prepare the first catalog of preference elicitation methods in health as part of the Patient-Centered Benefit-Risk Assessment Framework sponsored by the Medical Device Innovation Consortium. He is a founding member of the International Academy of Health Preference Research (IAHPR).
Dr. Gonzalez has more than 30 peer-reviewed publications using stated-preference methods, including several papers featuring novel analytical methods and applications in health. His work has been published in peer-reviewed journals, including British Journal of Dermatology, Headache, Vaccine, Social Science & Medicine, Value in Health, and Journal of Patient Preference and Adherence, as well as a textbook on preference valuation in environmental economics: Preference Data for Environmental Valuation: Combining Revealed and Stated Approaches.